The medical technology group Philips NL0000009538 is once again looking more optimistically at the current year.

The background to this is the recent tariff agreement between the US and the European Union. This is expected to impact 2025 results by 150 to 200 million euros, Siemens' Dutch competitor DE0007236101 Healthineers DE000SHL1006 announced in Amsterdam on Tuesday. Philips had previously expected 100 million euros more.

CEO Roy Jakobs therefore forecast a margin on adjusted earnings before interest, taxes, and intangible assets (EBITA) of 11.3 to 11.8 percent for 2025, up 0.5 percentage points from the previous guidance. US tariffs are likely to have an impact in the third quarter, which is why Philips expects a decline in the adjusted operating margin in these three months compared to the previous year.

Philips left its sales forecast unchanged. The company continues to expect organic growth (excluding currency and portfolio effects) of one to three percent. Siemens Healthineers DE000SHL1006 will present its quarterly figures on Wednesday. Analysts also see upside potential for this forecast. Both companies had lowered their earnings outlook in the previous quarter due to US tariff policy.

In the second quarter, Philips further announced that sales fell by around three percent to just over €4.3 billion. On a comparable basis, however, this represents an increase of one percent. Adjusted operating profit improved from €495 million to €540 million, thus exceeding analysts' expectations. The Dutch company earned €240 million less than the previous year's €452 million. At that time, however, Philips had benefited from an insurance payout.